Establishment Labs (NASDAQ: ESTA) revenue
Establishment Labs reported revenue of $211.1m for fiscal 2025, 27.1% more than in fiscal 2024 ($166.0m). Since fiscal 2017 its revenue has grown by 508.6%, an average growth of 25.3% a year.
Establishment Labs has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 9 fiscal years on record. The biggest drop was in fiscal 2020, −5.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $211.1m | +27.1% | −$39.0m | −18.5% |
| 2024 | $166.0m | +0.5% | −$50.0m | −30.1% |
| 2023 | $165.2m | +2.1% | −$65.0m | −39.4% |
| 2022 | $161.7m | +27.6% | −$39.7m | −24.5% |
| 2021 | $126.7m | +49.6% | −$25.1m | −19.8% |
| 2020 | $84.7m | −5.5% | −$27.9m | −33.0% |
| 2019 | $89.6m | +46.3% | −$30.9m | −34.5% |
| 2018 | $61.2m | +76.5% | −$23.9m | −39.0% |
| 2017 | $34.7m | — | −$20.0m | −57.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Establishment Labs revenue compared with its sector
By revenue for its latest fiscal year, Establishment Labs ranks 246th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Establishment Labs, 27.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 244th | IDEAYA Biosciences | $218.7m | 3,024.4% |
| 245th | Vanda Pharmaceuticals | $216.1m | 8.7% |
| 246th | Establishment Labs | $211.1m | 27.1% |
| 247th | Cytek Biosciences | $201.5m | 0.5% |
| 248th | SI-Bone | $200.9m | 20.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Establishment Labs
- How much revenue did Establishment Labs make in fiscal 2025?
- Establishment Labs reported revenue of $211.1m for fiscal 2025, compared with $166.0m in fiscal 2024.
- How much has the revenue of Establishment Labs grown?
- Between fiscal 2017 and fiscal 2025 it went from $34.7m to $211.1m: 508.6% more, an average growth of 25.3% a year.
- What was the best year for revenue at Establishment Labs?
- Of its last 9 fiscal years, fiscal 2025, with $211.1m.
- Where does Establishment Labs rank in its sector by revenue?
- It ranks 246th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Establishment Labs come from?
- From the annual report (Form 10-K) that Establishment Labs files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Establishment Labs files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Establishment Labs: the Establishment Labs page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.